Is suppressing immunity harmful to Lyme disease patients?
The authors compared 16 individuals with Lyme disease receiving TNF-α inhibitors with 32 healthy controls to understand whether suppressing their immunity is harmful. The individuals had confirmed Lyme disease with an erythema migrans rash manifestation. The patients received immune-suppressing medications, which included adalimumab, infliximab, etanercept, golimumab. These were often combined with other immunosuppressant drugs for […]
Is suppressing immunity harmful to Lyme disease patients? Read More »